Local resection of choroidal melanoma: Weighing the pros and cons

Article

Resection techniques for choroidal tumours are based on modern vitreoretinal surgical techniques, which allow for the treatment of more challenging cases.

Local resection of choroidal melanoma:

Resection of choroidal tumours is a treatment option but it is technically challenging and more challenging than removing tumours in the iris and ciliary body because the choroid is less accessible.1

In a review of the literature on surgical procedures to remove choroidal tumours via endoresection (ab interno) or transscleral resection (ab externo), Spanish investigators found that local resection may offer better visual results and eye sparing without compromising local tumour control and survival, but there are come caveats attached,1 according to lead author Dr Josep Maria Caminal, MD, from the Department of Ophthalmology, Ocular Oncology and Vitreoretinal Service, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain.

The investigators used the PubMed database of the U.S. National Library of Medicine and the Cochrane Central Register of Controlled Trials of the Cochrane Library to compare the 2 methods of choroidal tumour excision for visual outcomes, survival rates, and complications.

Twenty-five studies met the inclusion criteria; 12 studies described exoresection (6 retrospective studies and 6 comparative studies) and 13 describedendoresection (11 retrospective and 2 comparative studies).

The investigators reported that both surgeries are indicated to remove large tumours with thicknesses exceeding 8 mm with small base diameters. In addition to eliminating the risk associated with radiotherapy, surgery provides clinicians the opportunity to obtain histopathologic and cytogenetic data from surgical specimens. However, both surgeries are challenging and carry the risk of severe early and late postoperative complications.

Dr Caminal and colleagues provided the following key points:

“Choroidal tumour resection is an alternative to brachytherapy in selected cases. The available data suggest that this approach may offer better visual results and eye sparing without compromising local tumour control and survival.

Resection techniques for choroidal tumours are based on modern vitreoretinal surgical techniques, which allow for the treatment of more challenging cases.

The main limitations to surgical resection of these tumours are the risk of severe complications, which may include retinal detachment, proliferative vitreoretinopathy, severe intraoperative hemorrhage, air embolism, and local tumour recurrence at the resection edge.

Surgical resection of uveal melanomas should be limited to centers with substantial experience in the management of intraocular tumours.”

Reference
  1. Caminal JM, Lorenzo D, Gutierrez C, et al. Local resection in choroidal melanoma: a review. J Clin Med 2022;11:7156; https://doi.org/10.3390/jcm11237156

Recent Videos
3 experts are featured in this series.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
AAO 2024: Bonnie An Henderson, MD, talks about advancing medical education with AI, robotics, and diverse learning methods
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Related Content
© 2024 MJH Life Sciences

All rights reserved.